Previous close | 105.32 |
Open | 108.20 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's range | 108.20 - 108.20 |
52-week range | 108.20 - 108.20 |
Volume | |
Avg. volume | N/A |
Market cap | 13.782B |
Beta (5Y monthly) | 1.30 |
PE ratio (TTM) | 6.06 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
DALLAS, March 01, 2023--Celanese Announces Collaboration with Alessa Therapeutics for the Advancement of Oncology Treatments
DALLAS, February 28, 2023--Celanese Announces Hytrel® Price Increases
DALLAS, February 23, 2023--Celanese Corporation (NYSE: CE), a global chemical and specialty materials company, today reported highest-ever GAAP diluted earnings per share of $17.41 and second-highest ever adjusted earnings per share of $15.88 for full year 2022. The Company generated record net sales of $9.7 billion in the year, an increase of 13 percent over the prior record set in 2021. Full year net sales reflected increases in pricing and volume of 11 percent and 6 percent over 2021, respect